WKL:EURONEXT AMSTERDAMWolters Kluwer N.V. Analysis
Data as of 2026-09-02 - not real-time
€68.06
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Wolters Kluwer N.V. trades at €68.06, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 13.5% over the past 30 days. With RSI at 51.4 the momentum picture is neutral, alongside a bearish MACD signal. Watch an unavailable price as support and €72.56 as the nearer resistance level.
The shares look undervalued, trading on 11.6 times earnings below a sector average of 28.6. Analyst price targets sit 30.8% above the current price. The 3.67% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With a beta of 0.43 and a maximum drawdown of 100.0%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.
The shares look undervalued, trading on 11.6 times earnings below a sector average of 28.6. Analyst price targets sit 30.8% above the current price. The 3.67% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With a beta of 0.43 and a maximum drawdown of 100.0%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.
Top Market Events
Wolters Kluwer N.V. has reported first-quarter 2026 results with 4% revenue growth in constant curreWolters Kluwer stock is trading steadily ahead of an early September ex-dividend date, with recent bWolters Kluwer continues its 2026 share repurchase program with fresh transactions reported for June
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 70.23
- MACD momentum is negative
- 30-day price change of +13.5%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 11.6 versus sector average of 28.6
- Trading below the 200-day average of 70.23
- Analyst targets imply +30.8% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 11.6 versus sector average of 28.6
- Analyst targets imply +30.8% versus the current price
- Profit margin of 21.9% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth-0.60%
Profit Margin21.86%
P/E Ratio11.6
ROE146.14%
ROA9.76%
Debt/Equity590.21
P/B Ratio19.3
Op. Cash Flow€1.7B
Free Cash Flow€1.2B
Industry P/E28.6
Technical Analysis
TrendNeutral
RSI51.4
Support€0.00
Resistance€72.56
MA 20€66.44
MA 50€64.03
MA 200€70.23
MACDBearish
VolumeDecreasing
Fear & Greed Index92.04
Valuation
Fair Value€52.92
Target Price€89.03
Upside/Downside30.82%
GradeUndervalued
TypeValue
Dividend Yield3.67%
Risk Assessment
Beta0.43
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.